FIRST-TRIMESTER USE OF SSRIs AND THE RISK OF BIRTH DEFECTS   September 18, 2007

According to the March of Dimes approximately 10% of pregnant w  Continue reading ⇒

AVANDIA (ROSIGLITAZONE) AND CARDIOVASCULAR RISK   September 18, 2007

Avandia (generically known as rosiglitazone) is a form of thiazolidinedione drug commonly used to lower blood glucose levels in patients with type 2 diabetes. Thiazolideinesdiones, prescribed in normal doses, decrease glycated hemoglobin levels by an average of about 1 one percentage point or less. Continue reading ⇒

AVANDIA vs. ACTOS - The Winner Is!   September 18, 2007

The Cleveland Clinic has found that while Avandia increases tthe risks of heart attack, stroke and death, its chief competitior Actos, lowers the risk of heart attack, stroke and death in patients who use Actos to manage diabetes.  Continue reading ⇒

Avandia Linked to PPH/PAH   September 18, 2007

Avandia a drug manufactured by GlaxoSmithKine for the treatment of Type II Diabetes has been linked to several heart related adverse events including cases of primary pulmonary hypertension, PAH, heart attacks, strokes, congestive heart failure, edema and fluid retention. Prior claims that the drug was heart protective seem to be untrue. Continue reading ⇒

In: Tags:
Viagra Linked to Blindness   September 12, 2007

Viagra Blindness - Rare Coincidence or Side Effect?

The Food and Drug Administration (FDA) is currently engaged in discussions with Pfizer over the possible link between the use of Viagra (sildenafil citrate) and the development of serious vision problems that could result in blindness. Continue reading ⇒

Glaxo shares slide again as Avandia worries grow   May 30, 2007

GlaxoSmithKline lost another £1.6 billion in value today after brokerage Merrill Lynch issued a sell note saying that the adverse publicity around its diabetes drug, Avandia, would hit sales for at least two years even if it was not forced to withdraw it. Continue reading ⇒

Advocacy group says FDA knew Avandia’s risk   May 23, 2007

WASHINGTON - U.S. health authorities were aware of heart risks linked to GlaxoSmithKline Plc's widely prescribed diabetes drug Avandia and another competitor nearly five years ago, consumer advocacy group Public Citizen said on Tuesday. Continue reading ⇒

WARNING: PROTOPIC USERS MAY EXPERIENCE SEVERE SIDE EFFECTS, CANCER   May 21, 2007

The FDA issued a health warning in March 2005 for the topical Eczema creams Protopic and Elidel, after recommendations from the FDA's Pediatric Advisory Committee during its February 15, 2005 meeting due to the risk of cancer (including skin cancer and lymphoma) associated with these drugs, especially in young children. Continue reading ⇒

In: Tags:
Proton Pump Inibitors Prevacid, Prilosec, and Nexium link with hip fracture   May 21, 2007

On December 27, 2006, a report was published in the Journal of the American Medical Association (JAMA), that showed the correlation between powerful antacid drugs called "proton pump ihibitors", including Nexium, Prilosec and Prevacid, and the increased risk of hip fractures. Continue reading ⇒

In: Tags:
KETEK LINKED TO LIVER FAILURE, DRUG COMPANY DOCTOR CONVICTED OF FRAUD   May 21, 2007

Usage:

Ketek, known generically as telithromycin, is an antibiotic used for the treatment of respiratory infections including chronic bronchitis, acute bacterial sinusitis and community-acquired pneumonia. Ketek is manufactured by the French pharmaceutical giant Sanofi-Aventis.  Continue reading ⇒

Lawsuits of Interest

Accutane  (isotretinoin)
Advair  (Fluticasone/salmeterol)
Arthritis Drugs
Asbestos / Mesothelioma
Avandia  (Rosiglitazone)
Bextra  (Valdecoxib)
Celebrex  (Celecoxib)
Chantix  (Varenicline)
Denture Cream
Digitek  (Digoxin)
Fill out this form for a free evaluation:
Please type your name.
Please type your email address.
Please select the cause of your injury.
Enter any information that you would lke us to know.